Key Takeaways NFG is expanding pipeline and storage assets to boost capacity, reliability and regulated earnings. Tioga Pathway and Shippingport Lateral are expected to add 395,000 Dth/day of capacity in late 2026. NFG plans $210-$250M in fiscal 2026 Pipeline & Storage spending to support rate base growth. National Fuel Gas (NFG - Free Report) is strengthening its pipeline network through pipeline and storage expansion projects and ongoing infrastructure modernization. These investments expand transportation capacity, enhance pipeline reliability and drive long-term regulated earnings growth.
National Fuel Gas is progressing with the Shippingport Lateral and Tioga Pathway expansion projects, both of which are expected to begin service in late 2026. Tioga Pathway is expected to provide 190,000 dekatherms per day (Dth/day) of capacity, while Shippingport Lateral is projected to add 205,000 Dth/day of transportation capacity. The company has launched the Line N System Upgrade Project, which will add 94,000 Dth/day of transportation capacity under a long-term contract with an investment-grade customer. The project replaces aging pipelines, improves system reliability and is expected to begin service in late 2028, supporting stable long-term cash flows.
National Fuel Gas aims to invest in the $210-$250 million range in Pipeline & Storage projects in fiscal 2026, supporting 5-7% long-term rate base growth and driving steady earnings expansion. NFG currently has 77 billion cubic feet (Bcf) of natural gas storage capacity and specializes in underground storage of natural gas.
According to the U.S. Energy Information Administration (“EIA”), nearly 44.9 bcf per day of new pipeline capacity is planned for 2026-2027. Favorable industry trends and NFG's disciplined capital investment plans are expected to support long-term Pipeline & Storage expansion and earnings growth.
Investments in Pipeline & Storage Boost Midstream OperationsAccording to the U.S. EIA, pipeline investments enhance transportation efficiency, reduce bottlenecks and improve energy delivery reliability. These investments also support rising oil and natural gas production, strengthen long-term fee-based cash flows and enhance connectivity among production regions, storage facilities and end markets.
Kinder Morgan (KMI - Free Report) is expanding its natural gas network through the Gulf Coast Express expansion, South System Expansion, Trident and Mississippi Crossing, increasing pipeline capacity, meeting rising power demand and supporting fee-based growth.
Energy Transfer LP (ET - Free Report) continues to expand its natural gas pipeline network through the Desert Southwest Pipeline, Hugh Brinson Pipeline and Mustang Draw projects, increasing transportation capacity and supporting EBITDA and cash flow growth.
NFG’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates an increase of 9.70% and 4.98%, respectively, year over year.
Image Source: Zacks Investment Research
NFG’s Returns on Equity (ROE)National Fuel Gas' trailing-12-month ROE is 20.62%, higher than the industry average of 10.94%.
Image Source: Zacks Investment Research
NFG’s Stock Price PerformanceIn the past month, the company’s shares have risen 4.2% against the industry’s 6.3% fall.
Image Source: Zacks Investment Research
NFG’s Zacks RankNFG currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming August 24, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) common stock between October 14, 2024 to May 4, 2026, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PEABODY ENERGY CORPORATION (BTU), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Happened?
On March 30, 2026, Peabody issued a press release lowering guidance concerning its Centurion mine’s first quarter 2026 output due to mining commissioning challenges.
On this news, Peabody’s stock price fell $3.82, or 9.7%, to close at $35.68 per share on March 30, 2026, thereby injuring investors.
Then, on May 5, 2026, Peabody disclosed that it had failed to complete its goal to fully ramp-up Centurion by March 2026 and that it was cutting guidance related to full year metallurgical segment volumes to reflect the increased cost and substantial volume decrease.
On this news, Peabody’s stock price fell $1.52, or 5.7%, to close at $25.00 per share on May 5, 2026, thereby injuring investors further.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Peabody’s overly optimistic March 2026 Centurion ramp-up date and promises regarding the Company’s inflated guidance fell short of reality when numerous issues at Centurion caused a significant delay to the mine’s ramp-up and Peabody’s first quarter metallurgical segment volumes; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Peabody common stock during the Class Period, you may move the Court no later than August 24, 2026 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements.
Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: [email protected],
Visit our website at: www.howardsmithlaw.com.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Jessica Inskip (@jessicainskip) takes us through today's Big 3. She highlights Mastercard (MA) as an opportunity within an AI gap she sees, Valero Energy (VLO) holding strong momentum into earnings season, and Bullish (BLSH) as a high-risk, high-beta trade pick.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Lamb Weston (LW - Free Report) . This company, which is in the Zacks Food - Miscellaneous industry, shows potential for another earnings beat.
This frozen foods supplier has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 10.51%.
For the most recent quarter, Lamb Weston was expected to post earnings of $0.61 per share, but it reported $0.72 per share instead, representing a surprise of 18.03%. For the previous quarter, the consensus estimate was $0.67 per share, while it actually produced $0.69 per share, a surprise of 2.99%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Lamb Weston lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Lamb Weston currently has an Earnings ESP of +0.98%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #2 (Buy) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 24, 2026.
When the Earnings ESP comes up negative, investors should note that this will reduce the predictive power of the metric. But, a negative value is not indicative of a stock's earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
, /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, will report second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. An earnings conference call and webcast are scheduled for the same day at 8:30 a.m. Central Time. CEO Alok Maskara and CFO Michael Quenzer will provide a summary of the company's financial results and outlook, followed by a question-and-answer session.
To participate in the earnings conference call, please call 800-267-6316 (U.S.) or +1 203-518-9783 (international) at least 10 minutes prior to the scheduled start time and use conference ID LIIQ226. The conference call will also be webcast live at www.investor.lennox.com.
A replay of the conference call will be available until August 5, 2026, by calling toll-free 800-839-5484 (U.S.) or +1 402-220-1522 (international). The call also will be archived on the company's investor relations website.
About Lennox
Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information is available at www.lennox.com.
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Truist Financial Corporation (TFC - Free Report) , which belongs to the Zacks Banks - Major Regional industry, could be a great candidate to consider.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 6.43%.
For the last reported quarter, Truist Financial came out with earnings of $1.09 per share versus the Zacks Consensus Estimate of $0.99 per share, representing a surprise of 10.10%. For the previous quarter, the company was expected to post earnings of $1.09 per share and it actually produced earnings of $1.12 per share, delivering a surprise of 2.75%.
Price and EPS Surprise
With this earnings history in mind, recent estimates have been moving higher for Truist Financial. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Truist Financial has an Earnings ESP of +0.23% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on July 17, 2026.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
WINCHESTER, Va.--(BUSINESS WIRE)--Trex Company, Inc. [NYSE: TREX], the world's largest manufacturer of wood-alternative composite decking and railing, and a leader in high-performance, low-maintenance outdoor living products, will issue its second quarter 2026 earnings release on Tuesday, August 4, 2026, at 6:30 AM ET. You are invited to participate in the Company's conference call hosted by senior management on Tuesday, August 4, 2026, at 8:00 AM ET. Their prepared remarks will be followed by.
Trex Company, Inc. [NYSE: TREX], the world's largest manufacturer of wood-alternative composite decking and railing, and a leader in high-performance, low-main
Key Takeaways Marvell provides the backbone of the massive AI compute buildout. Big tech hyperscalers are moving more toward the custom silicon that MRVL builds. MRVL shares are retreating to the rising 10-week moving average - offering an attractive buy zone. What Does Marvell Do?Marvell Technology ((MRVL - Free Report) ) is a leading AI infrastructure company that powers the backend of AI data centers. To train AI models, thousands of GPUs are grouped together. Moving data between these GPUs is critical. Marvell provides the connectivity and optics solutions to ensure that massive amounts of data can fly through fiber optic cables at blistering speeds. Additionally, Marvell provides custom-designed chips for hyperscalers like Amazon ((AMZN - Free Report) ) and Alphabet ((GOOGL - Free Report) ). The custom-designed chips are tailored specifically to the big cloud provider’s data centers, helping them to save on power costs.
Marvell: An AI BeneficiaryAI has been the fastest and most predictable growth industry on Wall Street. Marvell is already delivering record earnings numbers, but Wall Street analysts see the growth only just beginning. Zacks Consensus Estimates suggest that MRVL will achieve top-and-bottom-line growth of 40% or more through 2028.
Image Source: Zacks Investment Research
The Next Trillion Dollar CompanyA few months ago, Marvell CEO Matt Murphy gave the keynote speech at the Computex tech trade show in Taipei. Prior to Murphy’s speech, NVIDIA’s ((NVDA - Free Report) ) iconic CEO explained why Marvell will be the next trillion-dollar company:
“When you take a computing problem, and you disaggregate it into a lot of parts, and you distribute across the data center, what’s necessary is connectivity. That’s the reason why Matt’s doing so well. That’s the reason Marvell is so essential. That’s why you’re going to be the next trillion-dollar company.”
Because Jensen Huang is CEO of the most important AI company and has visibility into the industry that no one else has, he’s worth listening to. Meanwhile, Marvell and NVIDIA recently expanded their relationship which should help to shorten adoption cycles, and broaden Marvell’s addressable opportunities across AI infrastructure builds.
MRVL Follow the Trend“The trend is your friend until the end when it bends.” ~ Ed Seykota
Marvell has been one of the best-performing stocks over the past year, gaining 163% versus the S&P 500’s 20%.
Image Source: Zacks Investment Research
One of the best ways for intermediate investors to gauge the trend is to follow the 10-week moving average. MRVL shares are retreating to the 10-week moving average for the first time since March. The first retreat to the 10-week moving average after a major breakout offers an extremely favorable reward-to-risk zone.
Image Source: TradingView
Bottom Line
While NVIDIA supplies the AI brains, Marvell builds the nervous system. Regardless of who wins the AI software or hardware wars, the entire AI ecosystem fundamentally requires Marvell’s specialized connectivity and custom architecture to function.
Key Takeaways VRT expanded in Johor to boost AI and high-density computing infrastructure capacity across APAC. The site will make power, cooling and integrated infrastructure solutions, including liquid cooling systems. VRT shares have surged 88.6% year to date, while its Price/Book valuation stands above the sector. Vertiv (VRT - Free Report) is benefiting from the accelerating global demand for artificial intelligence (AI) infrastructure and its expansion in Malaysia is a strategic move to capture growth in the Asia-Pacific (APAC) region. In the first quarter of 2026, Vertiv reported robust organic sales growth across multiple regions, with the Americas leading at 44% organic growth and APAC up 12%. In 2026, the company expects high-30s organic growth in the Americas, mid-20s in APAC and a return to growth in EMEA in the second half of the year.
The expansion in Malaysia is part of VRT’s broader strategy to increase its manufacturing and service footprint across APAC. The company recently opened a new manufacturing facility in Johor, Malaysia, expanding its production capacity to meet rising demand for AI and high-density computing infrastructure across Asia. The site strengthens Vertiv’s regional manufacturing, engineering, logistics and deployment capabilities while enhancing supply-chain resilience.
It will manufacture advanced power, cooling and integrated infrastructure solutions, including liquid cooling systems and prefabricated power modules, supported by full-scale testing. The expansion is expected to accelerate the deployment of AI-ready data centers, reduce implementation risks and improve customer responsiveness across Southeast Asia, North Asia, Australia and New Zealand.
This expansion is part of a larger strategy at Vertiv to increase manufacturing capacity to meet rising demand in AI infrastructure. Its strong portfolio will continue to benefit the company’s top-line growth. For the second quarter of 2026, revenues are expected to be between $3.25 billion and $3.45 billion, reflecting confidence in sustained AI infrastructure spending.
VRT Faces Stiff CompetitionVertiv faces intense competition from Super Micro Computer (SMCI - Free Report) and Amphenol (APH - Free Report) . Both Super Micro Computer and Amphenol are expanding their AI infrastructure portfolios.
Super Micro Computer continues to broaden its AI infrastructure offerings through collaborations with AMD, Arm and NVIDIA. The company has introduced new rack-scale AI platforms and data center building blocks designed to accelerate the deployment of large-scale AI and agentic AI workloads, intensifying competition in AI-ready infrastructure.
Amphenol is also benefiting from rising AI infrastructure investments. In the first quarter of 2026, IT datacom accounted for approximately 41% of sales and grew 81% organically year over year, driven by accelerating investments in AI data centers and strong demand for high-speed connectivity and interconnect solutions.
Vertiv’s Share Price Performance, Valuation & EstimatesVRT’s shares have surged 94.4% in the year-to-date (YTD) period compared with the broader Zacks Computer & Technology sector's 14.7% growth. The Zacks Computers - IT Services industry declined 23.3% in the same time frame.
VRT's YTD Stock Performance
Image Source: Zacks Investment Research
Vertiv stock is trading at a premium, with a trailing 12-month Price/Book of 27.65X compared with the sector’s 10.63X. VRT has a Value Score of D.
VRT Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is pegged at $6.38 per share, which has increased 3.73% over the past 30 days. This indicates a 51.90% increase from the reported figure of 2025.
Vertiv currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways UEC now has two U.S. ISR platforms operating at Christensen Ranch and Burke Hollow.New header houses and Burke Hollow's first full-quarter contribution are expected to lift output.UEC holds $794M in liquid assets and no debt, but costs and sales timing remain volatile. Uranium Energy Corp. (UEC - Free Report) is moving from uranium optionality toward operational execution. The company now has two U.S. in-situ recovery platforms operating, giving investors a clearer production base.
The setup is still uneven. Liquidity and project depth support the longer-term case, but results may remain choppy while wellfields, approvals and sales timing settle.
How UEC Built a Two-Hub ISR PlatformUEC’s current operating base is anchored by Christensen Ranch in Wyoming and Burke Hollow in South Texas. Christensen Ranch feeds the Irigaray Central Processing Plant, while Burke Hollow is tied to the Hobson Processing Facility.
That hub-and-spoke structure gives UEC licensed processing capacity across two regions. Irigaray is licensed for up to 4 million pounds of uranium annually, and Hobson is licensed to process as much as 4 million pounds per year.
Burke Hollow commenced production on April 8, 2026, after approval from the Texas Commission on Environmental Quality. Christensen Ranch has already produced 276,516 pounds since its August 2024 restart.
Why Uranium Energy Sees More Volume AheadThe near-term production story rests on Christensen Ranch header houses and Burke Hollow’s first full-quarter contribution. Three new header houses in Wellfield 11 began production late in the third quarter of fiscal 2026 after state approval.
One additional header house was complete and awaiting approval, and five more were under construction in Wellfields 12 and the 10-extension. These additions are expected to lift fourth-quarter production as more infrastructure operates.
The third quarter of fiscal 2026 did not yet capture that full benefit. Preconditioning, leaching and precipitation costs were recorded before the related production volume was fully reflected.
UEC Growth Pipeline Extends Beyond Current MinesLudeman, Sweetwater and Roughrider form the next layer of UEC’s growth pipeline. At Ludeman, UEC completed a 240-hole delineation drilling program, while engineering for a satellite ion-exchange plant progressed.
Sweetwater adds scale to the Wyoming opportunity. The project has been designated as a FAST-41 transparency project, and UEC reached a permitting milestone with the Bureau of Land Management’s completeness review of its Plan of Operations for in-situ recovery operations.
At Roughrider, more than 80% of the planned 35,000-meter conversion core drilling program has been completed to support a planned pre-feasibility study. For peer context, Cameco Corporation (CCJ - Free Report) gives investors exposure to a larger uranium fuel-cycle company. Centrus Energy Corp. (LEU - Free Report) is more closely tied to nuclear fuel and enrichment.
Where Uranium Energy Still Faces Execution RiskExecution risk remains the main near-term issue. In the third quarter of fiscal 2026, UEC produced 32,195 pounds at a total cost of $54.61 per pound and a cash cost of $46.69 per pound.
Total cost per pound rose 25% sequentially, driven by lower production from late approvals and higher state taxes. Production-based royalties, ad valorem and severance tax per pound increased to $8.11 from $6.67 in the second quarter of fiscal 2026.
Sales timing also adds volatility. UEC made no sales in the third quarter of fiscal 2026 as management preserved inventory under its 100% unhedged strategy, which can leave quarterly revenues uneven.
The Zacks Consensus Estimate for UEC for fiscal 2026 is currently at a loss of 19 cents per share wider than the loss of 17 cents reported in fiscal 2025. The consensus for fiscal 2027 also suggests a loss of 11 cents per share as shown in the chart below.
Image Source: Zacks Investment Research
Shares of UEC have declined 27.8% in the past three months compared with the industry’s 6.7% fall.
Image Source: Zacks Investment Research
How UEC’s Ratings Fit This Uneven SetupThe bottom line is that UEC has a more tangible operating platform, but the investment case still depends on execution. Liquidity is a support, with $794 million of liquid assets at the end of the third quarter of fiscal 2026, including $488 million in cash and no debt.
UEC currently carries a Zacks Rank #4 (Sell). That rank points to near-term caution, as sales and costs remain sensitive to approvals, wellfield timing and market-driven sales decisions.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock’s Zacks Style Scores also lean weak. UEC has a VGM Score of F, with a Value Score of F, Growth Score of F and Momentum Score of D. Since Style Scores complement the Zacks Rank, those marks do not strengthen the near-term setup.
For investors, the contrast is clear. UEC’s inventory, liquidity and project base support a constructive long-term narrative, but the current Rank and Style Scores argue for patience until production stabilizes and estimate trends improve.
Key Takeaways UEC is tying U.S. uranium production to a broader nuclear fuel and critical-minerals strategy.UEC's UR&C is pursuing a U.S. conversion facility, with licensing steps still ahead.UEC's growth hinges on permits, wellfield performance, site selection and construction timing. Uranium Energy Corp. (UEC - Free Report) is increasingly tied to a broader U.S. nuclear fuel and critical-minerals story. The company has moved beyond a simple uranium price trade by pairing domestic in-situ recovery production with a proposed conversion platform.
That strategy gives UEC a place in supply-security discussions. Investors still need to separate the long-term theme from near-term execution.
How UEC Fits the U.S. Fuel Security PushUEC holds what it describes as the largest uranium resource base and most licensed production capacity in the United States. Its Wyoming and South Texas hub-and-spoke in-situ recovery operations total about 12 million pounds of licensed annual capacity.
The operating model matters because multiple mines can feed central processing infrastructure. Christensen Ranch is processed through the Irigaray Central Processing Plant, while Burke Hollow and Palangana feed the Hobson Processing Facility.
Cameco Corporation (CCJ - Free Report) provides a useful industry reference point because it is a large uranium and nuclear fuel supplier with exposure across the global fuel cycle. That makes Cameco a benchmark for assessing how far UEC must still go to turn domestic resources into durable fuel-cycle earnings.
Why Uranium Energy Is Chasing Conversion CapacityUEC’s next strategic layer is United States Uranium Refining & Conversion Corp., or UR&C. The subsidiary is pursuing a new uranium refining and conversion facility in the United States, which would move the company beyond mining and yellowcake production.
UR&C has received a U.S. Nuclear Regulatory Commission docket number for the planned conversion facility. Engineering and design work with Fluor is continuing, and the formal license application is expected after design work is completed and a site is selected.
Management views Western conversion capacity as an acute bottleneck. Centrus Energy Corp. (LEU - Free Report) , which is focused on nuclear fuel and high-assay low-enriched uranium, shows why investors are watching fuel-cycle infrastructure beyond mining.
UEC Growth Trend Depends on Permits and TimingPolicy support does not eliminate the need for approvals, construction and wellfield performance. At Christensen Ranch, three new header houses in Wellfield 11 began production late in the third quarter of fiscal 2026 after state approval, while one more was complete and awaiting approval.
Sweetwater reinforces the same point. The Wyoming project has FAST-41 transparency status, and the Bureau of Land Management completed its completeness review of UEC’s Plan of Operations for in-situ recovery operations.
Those milestones are useful, but timing remains central to the investment case. Site selection, licensing and construction will determine when strategic projects can shift from policy-aligned assets to economic contributors.
The Zacks Consensus Estimate for UEC for fiscal 2026 is currently pegged at a loss of 19 cents per share, wider than the loss of 17 cents reported in fiscal 2025. The consensus for fiscal 2027 also suggests a loss of 11 cents per share, as shown in the chart below.
Image Source: Zacks Investment Research
How Uranium Energy Adds Critical Mineral ExposureUEC’s Alto Paraná project in Paraguay gives the company an adjacent critical-minerals angle through titanium and vanadium. An independent report concluded that the project could contribute to the security and diversification of U.S. supply chains.
The preliminary economic assessment included two development cases. The first showed an net present value (NPV) of $419 million and a 21% post-tax internal rate of return, while the larger-scale case showed an NPV of $1.55 billion and a 25% post-tax internal rate of return.
That optionality broadens UEC’s strategic narrative. It does not replace the core uranium thesis, but it gives investors another asset tied to supply-chain diversification.
What UEC’s Ratings Say About This Trend TradeThe bottom line is that UEC’s thematic reach is expanding faster than its near-term stock signal. The company has licensed U.S. capacity, a conversion initiative and critical-mineral exposure, but investors still need proof that execution can become steadier.
UEC currently carries a Zacks Rank #4 (Sell). That short-term rating points to caution over the next one to three months, particularly while the company is still working through production variability, cost pressure and licensing milestones.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Style Scores reinforce that view. UEC has a VGM Score of F, Value Score of F, Growth Score of F and Momentum Score of D. Since higher Style Scores are generally more favorable, these weak grades suggest a less attractive setup across valuation, growth and price-action factors.
For now, the U.S. nuclear fuel and critical-minerals theme gives UEC a clearer strategic identity. The stock still needs cleaner execution, better momentum and more durable earnings support before that theme translates into a stronger signal.
This strategic partnership aims to enhance Kodiak’s energy infrastructure initiatives, providing scalable power generation solutions to meet increasing demand.
• Kodiak Gas Services shares are advancing steadily. Why is KGS stock trading higher?
Kodiak Gas Services entered a multi-year agreement with Baker Hughes, which includes an initial order for gas turbines and generators expected to deliver approximately one gigawatt of power capacity by 2030.
The initial order includes NovaLT16 and Frame 5 gas turbines, along with BRUSH generators, to support growing power demand from data centers and energy infrastructure.
The equipment will be deployed in key U.S. markets to provide flexible behind-the-meter power amid rising electricity demand and grid constraints.
This collaboration is designed to support the growing energy infrastructure needs, particularly for data centers, highlighting the importance of flexible and efficient power solutions.
KGS Technical Outlook: Key Levels and MomentumFrom a technical perspective, Kodiak Gas Services has shown a strong performance over the past year, with a notable 12-month gain of 109.58%. Currently, the stock is trading about 1.2% above its 20-day simple moving average (SMA) of $69.88 and 0.8% above its 50-day SMA of $70.16. The 200-day SMA, at $50.17, indicates a significant bullish trend, with the stock trading 41% above this level.
The Relative Strength Index (RSI) currently sits at 45.90, indicating a neutral momentum phase, suggesting that the stock is neither overbought nor oversold at this time. This level of RSI reflects a balanced market sentiment, while the moving averages indicate a potential bearish crossover with the 20-day SMA below the 50-day SMA.
Key Resistance: $77 — Nearby level where rebounds can stall. Key Support: $65 — Nearby level where buyers previously stepped in. KGS Earnings Preview And Analyst Price TargetsKodiak Gas Services is slated to provide its next financial update on Aug. 5 (estimated).
EPS Estimate: 75 cents (Up from 43 cents) Revenue Estimate: $385.56 million (Up from $322.84 million) Valuation: P/E of 89.5x (Indicates premium valuation) Analyst Consensus & Recent Actions: The stock carries a Buy rating with a consensus price target of $59.62. Recent analyst moves include:
Barclays: Overweight (Lowers target to $72 on July 8) Jefferies: Initiated with Buy (target $79 on June 4) Wells Fargo: Initiated with Overweight (Target $93 on May 27) How KGS Ranks On Momentum and ValuationBelow is the Benzinga Edge scorecard for Kodiak Gas Services, highlighting its strengths and weaknesses compared to the broader market:
Momentum: Bullish (Score: 94.96) — Stock is outperforming the broader market. Value: Weak (Score: 43.35) — Trading at a steep premium relative to peers. The Verdict: Kodiak Gas Services’ Benzinga Edge signal reveals a momentum-driven story, indicating strong performance in the market despite a weak value score. This suggests that while the stock is currently performing well, it may be trading at a premium compared to its peers.
KGS ETF Exposure and Passive Fund Flow Risk WisdomTree US SmallCap Dividend Fund (NYSE:DES): 1.03% Weight Significance: Because Kodiak Gas Services carries significant weight in this fund, any significant inflows or outflows will likely force automatic buying or selling of the stock.
KGS Stock Trades on WednesdayKGS Stock Price Activity: Kodiak Gas Services shares were up 1.47% at $68.01 at publication on Wednesday, according to Benzinga Pro data.
Photo via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Key Takeaways ON is divesting facilities in the Philippines and Pennsylvania to optimize its manufacturing footprint.ON expects the divestitures to deliver $35M in annual cost savings, fully realized in 2028.AI data center revenues rose more than 30% sequentially in Q1 and are expected to double in 2026. ON Semiconductor (ON - Free Report) or onsemi recently announced an agreement to divest its Tarlac, Philippines, manufacturing facility to Greatek Electronics and its Mountain Top, PA, facility to Silex Microsystems. Management said these actions are designed to optimize onsemi’s manufacturing footprint, direct investments toward the most scalable and competitive fabs, and improve long-term manufacturing economics. Importantly, both transactions include structured transition plans and long-term supply agreements, ensuring uninterrupted customer deliveries while production is gradually transferred across onsemi's remaining network. ON expects these divestitures to generate approximately $35 million in annual cost savings, with benefits beginning in 2027 and fully realized in 2028.
onsemi’s latest divestitures reinforce the company’s Fab Right manufacturing strategy by reducing exposure to less competitive manufacturing assets and concentrating production in higher-efficiency, technology-aligned facilities. Rather than simply shrinking its footprint, onsemi is reshaping its manufacturing network to improve utilization, lower structural costs and support higher-margin products in AI data centers, automotive and industrial markets. Combined with rising AI-related demand and a richer product mix, these initiatives should support more durable gross-margin expansion and stronger long-term profitability.
The latest divestitures are a natural extension of the Fab Right strategy that ON management has emphasized throughout 2026. On the first-quarter earnings call, onsemi highlighted that structural manufacturing changes have already contributed to three consecutive quarters of gross-margin expansion, with non-GAAP gross margin improving to 38.5% despite a challenging demand environment. The company guided for sequential gross-margin expansion through the remainder of 2026, citing ongoing Fab Right initiatives, improved factory utilization and a leaner manufacturing model.
The strategy also complements onsemi’s portfolio transformation. The company has been exiting lower-value products, prioritizing differentiated power and sensing solutions and investing in AI data center power, silicon carbide, gallium nitride, automotive electrification and intelligent sensing. The company’s management has noted that improving backlog visibility, healthier bookings and expanding AI data center demand are allowing onsemi to better leverage its manufacturing base. In the first quarter of 2026, AI data center revenues grew more than 30% sequentially, which the company expects to double year over year in 2026.
ON Faces Tough Competitiononsemi is facing significant competition from the likes of Texas Instruments (TXN - Free Report) and Navitas Semiconductor (NVTS - Free Report) .
Texas Instruments challenges onsemi primarily through scale and manufacturing efficiency. TXN’s $20 billion-plus 300mm capacity buildout, internalization of wafers, shutdown of older 6-inch fabs and rising utilization give it a structurally lower-cost model. Texas Instruments said first-quarter gross margin reached 58%, up 210 basis points (bps) sequentially and 120 bps year over year and implied further improvement as revenue growth, lower capital expenditure intensity and internal wafer production flow through. These factors allow TXN to compete aggressively in analog, embedded, power and data-center sockets while still operating at a far higher margin base.
Navitas is targeting high-power GaN and high-voltage SiC in AI data centers, grid infrastructure, performance computing and industrial electrification. Management said high-power revenues grew strongly, mix is shifting away from mobile, and gross margin improved to 39% (90 bps year over year and 30 bps sequentially) in the first quarter of 2026, with further gradual expansion expected through 2026. Navitas believes that focusing on high-power applications can gradually improve profitability over time because these markets typically carry better pricing and stronger long-term demand visibility.
ON’s Share Price Performance, Valuation & EstimatesShares of onsemi have appreciated 68.2% year to date, outperforming the broader Zacks Computer and Technology sector’s rise of 16.6%.
ON Stock Outperforms Sector
Image Source: Zacks Investment Research
The ON Semiconductor stock is trading at a premium, with a forward 12-month price/earnings of 24.32X, higher than the median of 19.6X. ON has a Value Score of D.
ON’s Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ON’s 2026 earnings is currently pegged at $3.09 per share, unchanged over the past 30 days, suggesting 31.5% growth from the 2025 reported figure.
On Semiconductor currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways Datadog topped $1 billion in quarterly revenues as first-quarter 2026 sales rose 32% year over year.DDOG unveiled 100 plus AI and security capabilities and acquired Adaptive ML to expand AI agents.Datadog forecasts 2026 revenues of $4.30-$4.34B despite margin, competition and macro risks. Datadog (DDOG - Free Report) shares have surged 88.7% year to date, comfortably outpacing the Zacks Computer and Technology sector's 14.8% growth and the Zacks Internet Software industry's 8% decline over the same stretch of trading.
The rally reflects growing investor confidence in Datadog's role as a core observability and security platform for enterprises navigating increasingly complex, AI-driven infrastructure. With first-quarter 2026 results confirming accelerating growth and management issuing upbeat forward guidance, the near-term setup still looks favorable for investors willing to ride out some volatility, even as rising costs and intensifying competition warrant a genuinely watchful eye.
DDOG Outperforms Sector, Peers YTD
Image Source: Zacks Investment Research
Catalysts Fuelling DDOG’s RallyDatadog's first-quarter 2026 results showed revenues climbing 32% year over year to $1,006 million, marking the company's first quarter above $1 billion and a sequential acceleration from 29% growth in the prior period. Customers with annual recurring revenues of $100,000 or more grew 21% year over year to about 4,550. Non-GAAP operating margin held at 22%, while free cash flow reached $289 million.
Momentum has continued into the current quarter. Last month, Datadog hosted its DASH 2026 conference, unveiling more than 100 new capabilities to help customers manage growing AI and security complexity, including expanded agentic tooling. On June 30, the company announced its acquisition of Adaptive ML, a startup building a Reinforcement Learning Operations platform, which will join Datadog AI Research to accelerate work on specialized AI agents trained on real-world observability signals. The company also achieved FedRAMP High certification during the quarter and launched GPU Monitoring to help customers better manage AI infrastructure spend.
Forward-Looking Guidance by DDOG Holds PromiseFor the second quarter of 2026, Datadog guided revenues between $1.07 billion and $1.08 billion, non-GAAP operating income to be $225-$235 million, and non-GAAP earnings per share between 57 cents and 59 cents.
The Zacks Consensus Estimate calls for 2026 revenues of $4.34 billion, up 26.62% year over year, with earnings pegged at $2.41 per share, up 17.56%, suggesting the current valuation gap is arguably well justified by Datadog's faster, AI-driven observability growth trajectory relative to the broader field.
For full-year 2026, management projected revenues between $4.30 billion and $4.34 billion, non-GAAP operating income to be $940-$980 million, and non-GAAP earnings per share between $2.36 and $2.44, underscoring continued confidence in sustained double-digit growth.
Headwinds Worth MonitoringDespite the strong trajectory, risks remain. GAAP operating margin was just 1% in the quarter, reflecting heavy stock-based compensation and continued R&D investment, including newly absorbed costs tied to the Adaptive ML deal. Continued reliance on large enterprise deals also introduces some lumpiness to quarterly bookings, and management has flagged macro uncertainty tied to trade policy and IT spending as ongoing watch items.
Valuation and Competitive LandscapeDatadog carries a Zacks Value Score of F, trading at a forward 12-month price-to-sales ratio of 19.2X, well above the industry median of 4.78X. That steep premium reflects Datadog's notably stronger growth profile relative to slower-growing peers, whose more modest multiples mirror decelerating or largely flat expansion.
DDOG’s P/S Valuation
Image Source: Zacks Investment Research
DDOG faces significant competition from the likes of International Business Machines (IBM - Free Report) , Cisco Systems (CSCO - Free Report) and Dynatrace Software (DT - Free Report) , among others. Cisco Systems has advanced 45.2%, while Dynatrace has gained 4.1% and International Business Machines has returned 3.4%, highlighting Datadog's clear outperformance against all three legacy and pure-play rivals alike.
Cisco Systems leans on its deep network-layer footprint and hardware relationships to push observability bundles into existing accounts, while Dynatrace differentiates through AI-driven causal analytics aimed squarely at large enterprise customers. International Business Machines folds observability into its broader hybrid-cloud and consulting stack, giving it reach but comparatively less focus. Datadog's unified platform keeps winning share, though Cisco Systems, Dynatrace, and International Business Machines each retain entrenched enterprise relationships that keep the observability and security market intensely contested heading into the second half of 2026.
ConclusionWith accelerating revenue growth, robust guidance and steady AI-driven innovation spanning GPU monitoring, agentic security tooling and the Adaptive ML acquisition, Datadog's growth story remains firmly intact. Despite thin GAAP margins and a crowded competitive field, the near-term outlook still tilts favorably enough for patient, growth-oriented investors to consider Datadog.
DDOG currently carries a Zacks Rank #2 (Buy) and a Growth Score of A, a favorable combination that offers a strong investment opportunity per the Zacks proprietary methodology. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Datadog (DDOG - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.
Therefore, the Zacks rating upgrade for Datadog basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Datadog imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for DatadogThis data analytics and cloud monitoring company is expected to earn $2.41 per share for the fiscal year ending December 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for Datadog. Over the past three months, the Zacks Consensus Estimate for the company has increased 103.4%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Datadog to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Key Takeaways Cognizant is broadening its AI capabilities by integrating Gemini Enterprise with Google Workspace. CTSH expects Q2 2026 revenues of $5.45-$5.52B, implying year-over-year growth of 3.8%-5.3%. CTSH faces softer discretionary spending, stiff IT services competition and margin pressure. Cognizant Technology Solutions (CTSH - Free Report) is strengthening its enterprise artificial intelligence (AI) portfolio by expanding its partnership with Alphabet’s (GOOGL - Free Report) cloud computing platform, Google Cloud. Through the collaboration, Cognizant is integrating Gemini Enterprise with Google Workspace into its consulting, implementation, and managed services offerings, enabling enterprises to accelerate generative AI adoption while improving workforce productivity and accelerating enterprise AI transformation.
The collaboration also enhances Cognizant's internal AI capabilities. The company plans to deploy Gemini Enterprise across more than 200,000 employees while training its workforce on Google Cloud's AI technologies to improve software engineering productivity and accelerate AI solution delivery.
Cognizant aims to strengthen its AI Builder strategy while enhancing its ability to execute large-scale enterprise AI transformation projects by first deploying these capabilities internally before rolling them out to customers. The expanded Google Cloud partnership is part of Cognizant's broader strategy to expand its enterprise AI ecosystem, reinforcing its capabilities across AI development, deployment and security.
Cognizant Deepens Enterprise AI PartnershipsCognizant continues to expand its enterprise AI ecosystem through strategic partnerships with Google Cloud, CrowdStrike (CRWD - Free Report) and Snowflake (SNOW - Free Report) , strengthening its capabilities in generative AI, intelligent agents, AI-powered cybersecurity and enterprise AI deployment.
Cognizant announced a broader collaboration with Snowflake to help enterprises operationalize AI at scale. As a launch partner for Snowflake Cortex-powered Intelligent Agents, Cognizant will help customers deploy AI agents that automate complex business workflows while leveraging governed enterprise data, enabling organizations to move AI applications from pilot projects to production faster.
Cognizant expanded its strategic alliance with CrowdStrike to help enterprises secure AI throughout its lifecycle. Cognizant will integrate the CrowdStrike Falcon platform into its AI Factory and Managed Cybersecurity Services, enabling organizations to securely deploy, govern and manage AI agents, models and infrastructure across enterprise environments.
CTSH Offers Strong Q2 GuidanceCognizant's expanding AI portfolio, growing enterprise AI engagements, and strengthening partner ecosystem are expected to support the company's top-line growth.
For the second quarter of 2026, Cognizant expects revenues to be in the range of $5.45-$5.52 billion, implying year-over-year growth of 3.8%-5.3%.
The Zacks Consensus Estimate for second-quarter 2026 revenues is pegged at $5.49 billion, indicating year-over-year growth of 4.59%.
The consensus mark for earnings is pegged at $1.38 per share, unchanged over the past 30 days. The figure implies a year-over-year increase of 5.34%.
Cognizant Struggles Despite Expanding AI PortfolioDespite an expanding AI portfolio and a strong partner base, Cognizant’s shares have plunged 47% in the year-to-date period against the broader Zacks Computer & Technology sector's return of 16.6%.
The company is facing softer discretionary spending, trade and policy uncertainty, and continued caution in parts of Products & Resources and Health Sciences. Stiff competition across the IT services industry, particularly in AI-enabled digital transformation, remains a key headwind.
Cognizant is also facing margin pressure and rising costs, as reflected in an 80-basis-point year-over-year decline in its first-quarter 2026 gross margin. The decline was due to the impact of integrated offerings and higher compensation costs.
ConclusionCognizant's expanding AI ecosystem and growing enterprise partnerships continue to strengthen its long-term growth prospects and support top-line expansion. However, challenging macroeconomic conditions, soft discretionary spending and stiff competition are expected to weigh on CTSH's near-term performance.
Cognizant currently carries a Zacks Rank #3 (Hold), You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or performance. Authors/presenters may own the stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any specific investment strategies. Information is subject to change without notice. For information on use of our services, please see our Terms of Use.
*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet.
IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.
Investors interested in stocks from the Computer- Storage Devices sector have probably already heard of Teradata (TDC) and NetApp (NTAP). But which of these two companies is the best option for those looking for undervalued stocks?
New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AeroVironment, Inc. (NASDAQ: AVAV) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/AVAV.
AeroVironment Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:
AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; accordingly, Defendants overstated AeroVironment's business and financial prospects; and as a result, Defendants' public statements were materially false and misleading at all relevant times.What's Next for AeroVironment Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/AVAV, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in AeroVironment you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to AeroVironment Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for AeroVironment Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299085
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV) have opportunity to lead the securities fraud class action lawsuit.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AEROVIRONMENT, INC. (AVAV), CLICK HERE BEFORE JULY 27, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
What Is The Lawsuit About?
The complaint filed alleges that, between June 25, 2025 and March 10, 2026, Defendants failed to disclose to investors that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (2) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz,
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AeroVironment To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in AeroVironment between June 25, 2025 and March 10, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - July 8, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV) and reminds investors of the July 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (2) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding AeroVironment's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the AeroVironment class action, go to www.faruqilaw.com/AVAV or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the AeroVironment Securities Class Action Lawsuit:
What is the AeroVironment securities fraud lawsuit about?
The AeroVironment securities fraud lawsuit is a federal securities class action alleging that AeroVironment, Inc. (NASDAQ: AVAV) and its executives made false and misleading statements to investors by concealing that the Company faced imminent competition for its SCAR program contracts and overstating its business and financial prospects. As the truth emerged through a series of disclosures - including a U.S. government stop work order on January 20, 2026, a Space Force announcement that it was reopening the SCAR program on March 2, 2026, and AeroVironment's disclosure of a $151.3 million goodwill impairment and contract termination on March 10, 2026 - AVAV's stock price dropped sharply, causing significant losses for investors.
Who may be eligible to participate in the lawsuit?
Investors who purchased or acquired AeroVironment (AVAV) stock between June 25, 2025 and March 10, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the AeroVironment securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former AeroVironment employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff in the AeroVironment class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any AeroVironment investor who purchased AVAV stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 27, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased AeroVironment stock during the Class Period?
Investors who purchased AeroVironment (AVAV) stock between June 25, 2025 and March 10, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the AeroVironment securities class action is July 27, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/AVAV for more information.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased AeroVironment securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304418
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Key Takeaways Valmont Industries is benefiting from strong utility infrastructure demand and multi-year grid investments.VMI improved margins through restructuring, AI-enabled planning and added capacity, boosting efficiency.VMI raised 2026 earnings guidance and Infrastructure revenue outlook on stronger execution and demand. Valmont Industries, Inc.’s (VMI - Free Report) shares have rallied 34.1% year to date. While the company has underperformed the Zacks Steel - Pipe and Tube industry's rise of 40.1%, it topped the S&P 500's gain of 10.4%.
The rally has been driven by Valmont’s successful implementation of operational improvement strategy, robust demand in the Utility end-market, increased 2026 earnings guidance and upward revisions in earnings estimates that have strengthened the company’s long-term growth outlook.
Image Source: Zacks Investment Research
Let’s take a look at the factors that are driving VMI stock.
Robust Utility Demand and Margin Gains Drive VMI's UpsideValmont Industries' rally has been primarily driven by robust utility infrastructure demand and the company's operational improvement initiatives. The Infrastructure segment continues to benefit from a multi-year investment cycle supported by grid modernization, electrification and rising electricity demand from AI-driven data centers.
Management expects approximately $1.4 trillion of U.S. grid investments through 2030, creating a strong pipeline for transmission, distribution and substation projects. This resulted in healthy backlog growth, improving revenue visibility and higher confidence in sustained demand.
At the same time, VMI has significantly strengthened profitability through restructuring, productivity improvements and strategic capacity expansion. Corporate expenses declined as restructuring initiatives streamlined operations.
Brownfield expansion projects added approximately $95 million in annual revenue capacity. The company has also removed production bottlenecks, implemented AI-enabled scheduling and planning tools, and continued operational excellence initiatives that have improved manufacturing efficiency. These efforts have driven some of the strongest Infrastructure segment margins in recent years while positioning the company to capitalize on rising utility demand.
Reflecting the combined benefits of demand trends and improved execution, management raised its 2026 earnings guidance and increased Infrastructure segment revenue expectations. With expanding capacity, higher operating efficiency, improving margins and sustained exposure to long-term utility infrastructure investments, VMI remains well positioned to deliver higher revenue and earnings growth over the coming years.
VMI’s Zacks Rank & Other Key PicksVMI currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While ALB sports a Zacks Rank #1 (Strong Buy) at present, CRS and ASM carry a Zacks Rank #2 each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.98 per share, indicating a 1,743.04% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed one, with an average surprise of 74.5%. ALB’s shares have jumped 90.5% over the past year.
The Zacks Consensus Estimate for CRS’ 2026 earnings is pegged at $10.56 per share, indicating a rise of 41.18% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.95%.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 34 cents per share, indicating a 17.24% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%. ASM’sshares have gained 86.4% over the past year.
PTC Therapeutics (PTCT - Free Report) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
Therefore, the Zacks rating upgrade for PTC Therapeutics basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for PTC Therapeutics imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for PTC TherapeuticsFor the fiscal year ending December 2026, this biopharmaceutical company is expected to earn $0.78 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for PTC Therapeutics. Over the past three months, the Zacks Consensus Estimate for the company has increased 152.2%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of PTC Therapeutics to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Key Takeaways Oil-energy stocks are up 17.9% year to date, beating the Zacks S&P 500 composite's 10.4% rise.Cenovus Energy trades below its industry EV/EBITDA average with stable upstream and downstream operations.Par Pacific's diverse crude sourcing and cheaper Canadian heavy oil exposure support its refining edge. The oil-energy sector has seen a rally of 17.9% year to date, outperforming the Zacks S&P 500 composite’s increase of 10.4%. Geopolitical tensions in the Middle East have remained an important driver of oil prices, providing continued support to energy stocks.
Image Source: Zacks Investment Research
Investors should note that West Texas Intermediate (“WTI”) oil is currently trading below $75 per barrel, according to data from Oilprice.com, significantly down from the more than $100 per barrel mark reached in May this year. However, renewed tensions in the Middle East, following President Donald Trump's statement that the ceasefire agreement with Iran is no longer in effect, are once again supporting oil prices.
With the strong gain in the oil-energy space, it might have been difficult to find undervalued energy stocks that could create great value for investors’ portfolios. However, employing our proprietary stock screener, we have identified two cheap stocks that may not stay undervalued once the crowd catches on. The two stocks are Cenovus Energy Inc. (CVE - Free Report) and Par Pacific (PARR - Free Report) .
Bet on 2 Cheap Energy Stocks Right Away: CVE, PARRCenovus Energy is an integrated energy player with a presence in upstream and downstream businesses. With core operations in Canadian oil sands and North American refining, the company’s business model is relatively stable and can withstand the volatility in oil prices.
Currently, Cenovus Energy is undervalued, with a trailing 12-month enterprise value to EBITDA (EV/EBITDA) of 6.28x. This is below the broader industry average of 6.45x.
Par Pacific is benefiting from a refining business that remains well-positioned in the current crude-price environment. Although geopolitical tensions have recently supported crude prices, oil remains well below the highs seen earlier this year. The current price scenario continues to provide refiners like Par Pacific with relatively attractive feedstock costs.
Instead of relying on a single source of crude, PARR has been depending on crude from a variety of sources, comprising U.S. inland oil fields, imported oil delivered by ship and Canadian heavy crude.
Notably, a significant portion of crude oil sources is waterborne, while 22% consists of Canadian heavy oil. While exposed to multiple sources, Par Pacific has the option to switch if the price of one crude oil type rises.
Additionally, having exposure to Canadian heavy oil, which is cheaper than lighter crude, Par Pacific is likely to have been enjoying a cost advantage. In other words, the refining player has been capable of using lower-priced fuel to produce high-value end products, giving it an edge over other refiners and helping it continue its upward trajectory.
Coming to the valuation story, PARR is currently trading at a discount. The stock is trading at a trailing 12-month EV/EBITDA multiple of 4.84x, which is lower than the broader industry average of 5.50x.
Image Source: Zacks Investment Research
Last WordsGiven their discounted valuations and favorable industry positioning, both Cenovus Energy and Par Pacific appear well-positioned to gain. Both stocks sport a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Alarm.com Holdings (ALRM - Free Report) . This company, which is in the Zacks Security and Safety Services industry, shows potential for another earnings beat.
This security service company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 8.71%.
For the most recent quarter, Alarm.com was expected to post earnings of $0.6 per share, but it reported $0.65 per share instead, representing a surprise of 8.33%. For the previous quarter, the consensus estimate was $0.66 per share, while it actually produced $0.72 per share, a surprise of 9.09%.
Price and EPS Surprise
For Alarm.com, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Alarm.com has an Earnings ESP of +1.54% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Investors looking for stocks in the Diversified Operations sector might want to consider either Mitsui & Co. (MITSY - Free Report) or Carlisle (CSL - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Right now, Mitsui & Co. is sporting a Zacks Rank of #2 (Buy), while Carlisle has a Zacks Rank of #3 (Hold). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that MITSY is likely seeing its earnings outlook improve to a greater extent. But this is just one factor that value investors are interested in.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
MITSY currently has a forward P/E ratio of 12.04, while CSL has a forward P/E of 16.72. We also note that MITSY has a PEG ratio of 1.05. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CSL currently has a PEG ratio of 1.11.
Another notable valuation metric for MITSY is its P/B ratio of 1.37. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, CSL has a P/B of 8.66.
These metrics, and several others, help MITSY earn a Value grade of A, while CSL has been given a Value grade of C.
MITSY stands above CSL thanks to its solid earnings outlook, and based on these valuation figures, we also feel that MITSY is the superior value option right now.
New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Verra Mobility Corporation (NASDAQ: VRRM) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Verra securities between February 24, 2026 and May 26, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/VRRM.
Verra Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
Defendants misrepresented the nature and stability of Verra's relationship with Avis Budget Group ("Avis"), including the likelihood of securing a contract extension; Defendants downplayed the risk that major rental car companies, including Avis, could replace Verra's services with in-house solutions or alternative third-party providers; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for Verra Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/VRRM, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Verra you have until August 4, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Verra Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Verra Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300546
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Verra Mobility Corporation (NASDAQ: VRRM) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Verra securities between February 24, 2026 and May 26, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/VRRM.
Verra Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
Defendants misrepresented the nature and stability of Verra’s relationship with Avis Budget Group (“Avis”), including the likelihood of securing a contract extension; Defendants downplayed the risk that major rental car companies, including Avis, could replace Verra’s services with in-house solutions or alternative third-party providers; and as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times. What's Next for Verra Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/VRRM. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Verra you have until August 4, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Verra Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Verra Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
LOS ANGELES, July 08, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 4, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Verra Mobility Corporation (“Verra” or the “Company”) (NASDAQ: VRRM) common stock between February 24, 2026 and May 26, 2026, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR VERRA INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On May 26, 2026, Verra disclosed that it had received a termination notice from Avis Budget Group regarding its contract. The Company accordingly lowered its full year 2026 financial outlook.
On this news, Verra’s stock price fell $9.23, or 70.6%, to close at $3.85 per share on May 27, 2026, thereby injuring investors.
On June 1, 2026, Verra announced that its President and Chief Executive Officer had been terminated as “the Board determined that a change in leadership [was] needed[.]”
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Verra’s optimistic plan for continued growth in its Commercial Services business was dependent on its relationship with Avis, and in particular obtaining a contract extension with Avis Budget; (2) the Company minimized concerns that major RACs could replace Verra with in-house solutions or outsourced alternatives, making Verra’s 2026 full year guidance increasingly unlikely to be met; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Verra common stock during the Class Period, you may move the Court no later than August 4, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Calix, Inc. (NYSE: CALX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Calix securities between January 28, 2026 and April 21, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CALX.
Calix Case Details
The Complaint alleges that throughout the Class Period, defendants failed to disclose to investors:
the Company's first quarter margins had significantly benefited from advanced purchasing of memory components; that the Company's advanced supply of memory components was dwindling; that, as a result, the Company was experiencing negative margin pressure as it was forced to purchase memory components at rising market prices; and that, as a result of the foregoing, Defendants' positive statements about the Company's margins, business, operations, and prospects were materially misleading and/or lacked a reasonable basis.What's Next for Calix Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CALX, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Calix you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Calix Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Calix Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299461
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Calix, Inc. (NYSE: CALX) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Calix securities between January 28, 2026 and April 21, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CALX.
Calix Case Details
The Complaint alleges that throughout the Class Period, defendants failed to disclose to investors:
(1)the Company’s first quarter margins had significantly benefited from advanced purchasing of memory components; (2)that the Company’s advanced supply of memory components was dwindling; (3)that, as a result, the Company was experiencing negative margin pressure as it was forced to purchase memory components at rising market prices; and (4)that, as a result of the foregoing, Defendants’ positive statements about the Company’s margins, business, operations, and prospects were materially misleading and/or lacked a reasonable basis. What's Next for Calix Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CALX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Calix you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Calix Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Calix Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Calix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Calix between January 28, 2026 and April 21, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - July 8, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Calix, Inc. ("Calix" or the "Company") (NYSE: CALX) and reminds investors of the July 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company's first quarter margins had significantly benefited from advanced purchasing of memory components; (2) that the Company's advanced supply of memory components was dwindling; (3) that, as a result, the Company was experiencing negative margin pressure as it was forced to purchase memory components at rising market prices; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's margins, business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On April 21, 2026, Calix reported results for the first quarter of 2026 earnings, including that "Non-GAAP gross margin was 57.2%, down 80 basis points sequentially." Further, the Company reported "gross margin guidance for the second quarter of 2026 is between 54.25% and 57.25%" and "[f]or the year, we expect our non-GAAP gross margin to decline between 50 and 150 basis points."
In the accompanying earnings call, the Company's CFO stated "advanced purchasing had allowed us to avoid higher memory component costs during the first quarter. However, that advanced supply has run its course, and we now face market prices."
On this news, Calix's stock price fell $6.93, or 13.98% to close at $42.65 per share on April 22, 2026, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Calix's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Calix class action, go to www.faruqilaw.com/CALX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the Calix Securities Class Action Lawsuit:
What is the Calix securities fraud lawsuit about?
The Calix securities fraud lawsuit is a federal securities class action alleging that Calix, Inc. (NYSE: CALX) and its executives made false and misleading statements to investors by concealing that the Company's strong first quarter margins were artificially inflated by advanced purchasing of memory components, that its advanced supply of those components was dwindling, and that it would soon be forced to purchase memory components at rising market prices - creating significant negative margin pressure. As the truth emerged on April 21, 2026, when Calix reported Q1 2026 results and its CFO disclosed that "advanced supply has run its course" and the Company would "now face market prices," CALX's stock price fell $6.93 per share, or 13.98%, causing significant losses for investors.
Who may be eligible to participate in the Calix class action lawsuit?
Investors who purchased or acquired Calix (CALX) stock between January 28, 2026 and April 21, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the Calix securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former Calix employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment in the Calix lawsuit?
A lead plaintiff in the Calix class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any Calix investor who purchased CALX stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 27, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased Calix stock during the Class Period?
Investors who purchased Calix (CALX) stock between January 28, 2026 and April 21, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the Calix securities class action is July 27, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/CALX for more information.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304420
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at LifeStance Health Group (LFST - Free Report) , a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. LifeStance Health Group currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market?Let's discuss some of the components of the Momentum Style Score for LFST that show why this outpatient mental health services provider shows promise as a solid momentum pick.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.
For LFST, shares are up 9.63% over the past week while the Zacks Medical - Outpatient and Home Healthcare industry is up 5.14% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 42.3% compares favorably with the industry's 12% performance as well.
While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Over the past quarter, shares of LifeStance Health Group have risen 67.43%, and are up 130.44% in the last year. In comparison, the S&P 500 has only moved 13.69% and 21.71%, respectively.
Investors should also pay attention to LFST's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. LFST is currently averaging 4,002,606 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with LFST.
Over the past two months, 1 earnings estimate moved higher compared to none lower for the full year. This revision helped boost LFST's consensus estimate, increasing from $0.11 to $0.12 in the past 60 days. Looking at the next fiscal year, 1 estimate has moved upwards while there have been no downward revisions in the same time period.
Bottom LineGiven these factors, it shouldn't be surprising that LFST is a #1 (Strong Buy) stock and boasts a Momentum Score of B. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep LifeStance Health Group on your short list.
Key Takeaways Arthur J. Gallagher acquired WMB to expand its retail commercial insurance business in Western Canada.AJG adds expertise in construction, commercial real estate, surety, hospitality and mining insurance. The acquisition supports Gallagher's strategy of expanding through targeted specialty insurance acquisitions. Specialty insurance remains a major growth pillar for Arthur J. Gallagher & Co. (AJG - Free Report) , driven by strong demand for customized coverage, deeper client relationships and stable commission-based revenues. The company continues to expand its specialty insurance platform through strategic acquisitions, reinforcing its position in niche commercial insurance markets.
The latest acquisition is Wilson M. Beck Insurance Services Inc. (WMB), a Canada-based retail insurance broker serving commercial clients across Western Canada. The WMB team, led by David Beck, will continue operating from its current locations and will be integrated into Gallagher's retail property and casualty brokerage operations in Canada.
The acquisition strengthens Gallagher's retail brokerage operations in Western Canada while expanding its presence in high-value commercial insurance segments. WMB's specialization in construction, commercial real estate, surety bonding, hospitality and mining will enhance AJG's expertise in these niche markets, which often involve complex risk exposures and customized coverage requirements. WMB’s expertise and client relationships are expected to help Gallagher to attract new commercial customers and drive stable commission-based revenues over the long term.
The transaction also aligns with Gallagher's broader strategy of growing through targeted acquisitions that complement its existing brokerage and consulting businesses. By adding WMB's industry expertise and regional presence, Gallagher is well-positioned to capitalize on the growing demand for specialized commercial insurance solutions while supporting its long-term growth strategy.
How Are Competitors Faring?Peers like Brown & Brown, Inc. (BRO - Free Report) and Aon plc (AON - Free Report) are also expanding their retail brokerage businesses through acquisitions.
BRO has been actively expanding its retail insurance brokerage business through acquisitions across North America. The acquisitions of Accession Risk Management Group, which significantly expanded its retail brokerage, employee benefits and programs businesses, as well as several regional retail agencies. These acquisitions have strengthened BRO's presence in niche commercial insurance markets and broadened its client base.
Aon has been expanding its commercial insurance brokerage platform through targeted acquisitions and strategic investments. The company expanded its middle-market brokerage capabilities by acquiring NFP, enhancing its commercial insurance, employee benefits and advisory offerings.
AJG’s Price Performance, Valuation & EstimatesShares of AJG have dropped 19.2% compared with the industry’s decline of 27%.
Image Source: Zacks Investment Research
From a valuation standpoint, AJG trades at a forward price-to-earnings ratio of 18.14X, higher than the industry average of 16.57X.
Image Source: Zacks Investment Research
The consensus estimate for earnings per share (EPS) for 2026 and 2027 indicates a year-over-year increase of 23.8% and 11.8%, respectively.
The Zacks Consensus Estimates for 2026 earnings moved 0.3% south, while the estimate for 2027 earnings moved 0.2% north in the last 30 days.
Image Source: Zacks Investment Research
The consensus estimates for AJG’s 2026 and 2027 revenues indicate a year-over-year increase.
AJG currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Headquartered in Los Angeles, Cathay General (CATY - Free Report) is a Finance stock that has seen a price change of 27.01% so far this year. The holding company for Cathay Bank is currently shelling out a dividend of $0.38 per share, with a dividend yield of 2.47%. This compares to the Banks - West industry's yield of 2.53% and the S&P 500's yield of 1.35%.
Looking at dividend growth, the company's current annualized dividend of $1.52 is up 11.8% from last year. Over the last 5 years, Cathay General has increased its dividend 1 times on a year-over-year basis for an average annual increase of 2.11%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Cathay's current payout ratio is 31%, meaning it paid out 31% of its trailing 12-month EPS as dividend.
Earnings growth looks solid for CATY for this fiscal year. The Zacks Consensus Estimate for 2026 is $5.42 per share, representing a year-over-year earnings growth rate of 19.38%.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. But, not every company offers a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. That said, they can take comfort from the fact that CATY is not only an attractive dividend play, but is also a compelling investment opportunity with a Zacks Rank of #2 (Buy).
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Based in Tulsa, ONE Gas (OGS - Free Report) is in the Utilities sector, and so far this year, shares have seen a price change of 0.76%. Currently paying a dividend of $0.68 per share, the company has a dividend yield of 3.49%. In comparison, the Utility - Gas Distribution industry's yield is 3.73%, while the S&P 500's yield is 1.35%.
Looking at dividend growth, the company's current annualized dividend of $2.72 is up 1.5% from last year. Over the last 5 years, ONE Gas has increased its dividend 5 times on a year-over-year basis for an average annual increase of 4.53%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. ONE Gas's current payout ratio is 60%, meaning it paid out 60% of its trailing 12-month EPS as dividend.
OGS is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $4.72 per share, with earnings expected to increase 5.36% from the year ago period.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. But, not every company offers a quarterly payout.
Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, OGS is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Cousins Properties (CUZ - Free Report) and EastGroup Properties (EGP - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.
Right now, Cousins Properties is sporting a Zacks Rank of #2 (Buy), while EastGroup Properties has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that CUZ has an improving earnings outlook. However, value investors will care about much more than just this.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
CUZ currently has a forward P/E ratio of 10.43, while EGP has a forward P/E of 22.39. We also note that CUZ has a PEG ratio of 2.26. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. EGP currently has a PEG ratio of 3.22.
Another notable valuation metric for CUZ is its P/B ratio of 1.12. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, EGP has a P/B of 3.23.
These are just a few of the metrics contributing to CUZ's Value grade of B and EGP's Value grade of D.
CUZ is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. And, based on the above valuation metrics, we feel that CUZ is likely the superior value option right now.
The latest USDA Egg Markets Overview paints a picture of a market that has shifted dramatically from just a year ago. National wholesale prices for loose, large shell eggs stood at $0.27 per dozen in the latest weekly report, while supplies were described as “moderate to heavy” and trading remained slow.
The agency also reported that total shell egg inventories rose 4% from the prior week, with large egg inventories increasing 6%.
The Biggest Loser May Be Cal-MaineNo company benefited more from soaring egg prices than Cal-Maine Foods Inc. (NASDAQ:CALM), the nation’s largest egg producer.
The bird flu outbreak sent wholesale egg prices to record levels over the past two years, driving exceptional revenue and profit growth across the industry. But the same pricing environment that fueled those earnings is beginning to fade.
USDA data now point to recovering supplies, growing inventories and significantly lower wholesale prices than those seen during the height of the shortage. While Cal-Maine continues to benefit from its scale and specialty egg portfolio, investors may increasingly focus on how quickly earnings normalize as pricing returns closer to historical levels.
Food Companies Could Quietly BenefitEggs are only one component of overall food costs, but the sharp reversal removes a pressure point that weighed on many food companies during the inflation surge.
The Investment Story Has ChangedThe USDA report suggests the market has moved beyond the emergency conditions created by bird flu.
Supplies are rebuilding, inventories are growing and retailers are once again promoting conventional eggs, with the average advertised price falling to $1.48 per dozen in the latest reporting week.
For consumers, that means cheaper breakfasts.
For investors, it may signal a shift in leadership.
Over the past two years, soaring egg prices created clear winners in egg production. As the market normalizes, the advantage could gradually shift toward the food manufacturers and restaurant operators that spent much of that period paying the bill.
Image via Shutterstock
Market News and Data brought to you by Benzinga APIs
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Victory Capital Holdings (VCTR - Free Report) , which belongs to the Zacks Financial - Investment Management industry.
When looking at the last two reports, this investment management firm has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 8.77%, on average, in the last two quarters.
For the last reported quarter, Victory Capital came out with earnings of $1.82 per share versus the Zacks Consensus Estimate of $1.65 per share, representing a surprise of 10.30%. For the previous quarter, the company was expected to post earnings of $1.66 per share and it actually produced earnings of $1.78 per share, delivering a surprise of 7.23%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Victory Capital lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Victory Capital has an Earnings ESP of +5.44% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Key Takeaways Oceaneering won a four-year Petrobras contract to provide offshore Brazil ROV services from 2027.OII will supply two work-class ROV systems and specialized tooling for offshore subsea operations.Oceaneering's Brazil team will execute the project using local expertise and established infrastructure Oceaneering International, Inc. (OII - Free Report) has strengthened its position as a leading subsea technology and offshore services provider after the Brazilian subsidiary, Marine Production Systems do Brasil LTDA (“MPS”), secured a new contract from Petrobras (PBR - Free Report) to deliver remotelyoperated vehicle (“ROV”) services offshore Brazil. The four-year agreement represents a significant milestone in Oceaneering’s continued support of complex deepwater operations and reinforces its long-standing partnership with one of the world’s largest offshore energy companies.
The contract was awarded following a competitive tender process and is expected to begin operations in 2027. Under the agreement, Oceaneering will provide advanced subsea capabilities designed to support Petrobras’ offshore intervention, installation and abandonment activities. The project highlights the increasing importance of reliable subsea robotics, specialized tooling and operational expertise in the development and maintenance of deepwater energy infrastructure.
Advanced ROV Solutions to Support Petrobras’ Offshore ActivitiesAs part of the contract, Oceaneering will supply two work-class ROV systems along with specialized tooling packages developed to support demanding offshore tasks. These advanced robotic systems will provide critical underwater capabilities, enabling precise inspection, intervention, monitoring and positioning support in challenging subsea environments.
The ROV technology will be deployed from AKOFS Offshore’s subsea engineering support vessel Aker Wayfarer, which Petrobras has contracted to perform a range of offshore intervention, installation and abandonment support scopes. By combining a highly capable subsea vessel with Oceaneering’s robotic technologies and engineering expertise, the project will deliver an integrated solution for complex offshore operations.
Oceaneering’s local Brazilian team will execute the project, bringing extensive regional knowledge, technical expertise and operational experience to Petrobras’ offshore campaigns. The use of a locally established team also supports efficient project execution while maintaining the high safety and performance standards required for deepwater activities.
Strengthening a Long-Term Partnership With PetrobrasOceaneering has supported Petrobras’ subsea engineering campaigns for more than a decade, establishing a strong relationship built on technical reliability, innovation and operational excellence. The latest contract award further expands this collaboration and provides additional long-term visibility in Brazil’s important deepwater market.
Simao Silva, Brazil country manager at Oceaneering, highlighted the importance of the agreement, noting that the award reflects Petrobras’ continued confidence in its ability to provide advanced subsea solutions for complex offshore environments.
The partnership demonstrates the value of combining global technology capabilities with local expertise. Through years of supporting offshore projects in Brazil, Oceaneering has developed a deep understanding of regional operational requirements and the technical challenges associated with deepwater energy production.
Oceaneering’s Nearly Three Decades of Operations in BrazilOceaneering has maintained a presence in Brazil for nearly three decades, developing a comprehensive infrastructure network to support offshore energy activities. Through MPS, the company operates multiple facilities that provide specialized services, including ROV operations, survey services, subsea intervention tooling and engineered solutions.
The company’s Brazilian operations include a dedicated center for ROV, Survey, Subsea Intervention Tooling and Engineered Solutions, as well as an Onshore Remote Operations Center located in Macaé. These facilities support offshore projects through advanced engineering, remote monitoring capabilities, equipment preparation and technical services.
Oceaneering also operates an umbilical manufacturing plant in Niterói, strengthening its ability to provide integrated subsea solutions within the Brazilian market. This local infrastructure enables the company to respond efficiently to the needs of offshore operators while supporting the country’s evolving energy sector.
Delivering Technology-Driven Offshore Energy SolutionsOceaneering’s latest Petrobras contract reflects its broader mission of delivering engineered services, advanced products and robotic solutions across multiple industries. The company combines decades of subsea experience with innovative technologies to improve offshore safety, efficiency and reliability.
Work-class ROV systems play a vital role in modern offshore operations by allowing operators to perform underwater activities with precision and reduced risk. These systems support essential tasks such as subsea inspection, equipment installation, maintenance activities and intervention operations at significant depths.
Through continuous investment in technology and skilled personnel, Oceaneering continues to advance the capabilities available to offshore operators worldwide. This agreement demonstrates how sophisticated robotics, engineering expertise and local operational knowledge can work together to support increasingly complex offshore projects.
Strong Future for Subsea Services in BrazilBrazil remains one of the world’s most important deepwater energy markets, with significant offshore resources and a growing demand for advanced subsea technologies. Oceaneering’s expanded collaboration with Petrobras positions it to continue contributing to major offshore developments while supporting safe and efficient operations.
The new four-year contract reinforces Oceaneering’s reputation as a trusted subsea services provider and highlights the company’s ability to deliver specialized solutions for challenging marine environments. With experienced teams, established facilities and advanced robotic technologies, Oceaneering is prepared to support the next generation of offshore operations in Brazil.
Through this agreement, Oceaneering and Petrobras continue a partnership focused on innovation, reliability and operational excellence, helping drive the future of deepwater subsea engineering and offshore energy development.
OII's Zacks Rank & Key PicksCurrently, OII and PBR have a Zacks Rank #3 (Hold) each.
Investors interested in the energy sector might look at some better-ranked stocks like Paramount Resources (PRMRF - Free Report) and Cenovus Energy (CVE - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Paramount Resources is valued at $2.83 billion. It is a Canadian energy company focused on the exploration, development and production of natural gas, crude oil and natural gas liquids. Paramount Resources stock has delivered 28.9% total return over the past year.
Cenovus Energy is valued at $45.32 billion. It is a Canadian integrated energy company engaged in the production of crude oil and natural gas, as well as refining, upgrading and marketing petroleum products, operating across Canada, the United States and the Asia-Pacific region. Cenovus Energy stock has delivered a 72.6% total return over the past year.
Key Takeaways Tetra Tech won a $15M, five-year LADWP contract for Owens Lake Dust Mitigation Program engineering services.TTEK will provide GIS mapping, hydraulic modeling, geotechnical and engineering design services.Tetra Tech recently also won a hydropower dam modernization contract from Chelan County PUD in Washington. Tetra Tech, Inc. (TTEK - Free Report) recently secured a $15 million contract from the Los Angeles Department of Water and Power (LADWP) to deliver engineering design and technical services for the Owens Lake Dust Mitigation Program. It is the largest dust mitigation and control program in the US.
Owens Lake is a significant dry lakebed where EPA-approved measures are used to control dust emissions and preserve the ecosystem over a 48.6-square-mile area. Per the five-year, multiple-award contract, TTEK’s engineers and digital automation specialists will provide geotechnical investigations, hydraulic modeling, cutting-edge GIS mapping, and civil, structural and mechanical engineering design services. The company will also deliver electrical and SCADA engineering design services to support current and new dust mitigation solutions.
Lately, Tetra Tech has received a series of deals that are likely to drive its growth. In June 2026, TTEK secured a contract from Chelan County Public Utility District (PUD) for the Hydropower Dam Spillway Modernization Project at the Rock Island and Rocky Reach hydroelectric dams in Washington. The company will serve as the lead design engineer as part of a team that includes Kuney Construction and J.F. Brennan.
Also, in April 2026, Tetra Tech secured a multi-year engineering and consulting contract from Waterschap Aa en Maas to support the expansion of wastewater treatment facilities and modernization of water infrastructure across the southern Netherlands. The company will provide wastewater treatment design, water resource management, flood defense, and environmental engineering solutions to help improve clean water availability and protect against flooding for approximately 780,000 residents and 17,000 businesses across 20 municipalities.
TTEK’s Zacks Rank and Price PerformanceTetra Tech is benefiting from its diversified business model, strong demand across client sectors and a robust backlog, supporting revenue growth and prompting it to raise its fiscal 2026 revenue outlook.
TTEK currently carries a Zacks Rank #3 (Hold). Shares of the company have gained 10.3% in the past month against the industry’s 4.8% decline.
Image Source: Zacks Investment Research
Rising costs could weigh on TTEK’s profitability in the coming quarters. The company’s international presence exposes it to currency swings and economic challenges in global markets.
Stocks to ConsiderSome better-ranked companies from the same space are discussed below:
Cardinal Infrastructure Group Inc. (CDNL - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cardinal Infrastructure delivered an earnings surprise of 27.8% in the last reported quarter. In the past 60 days, the consensus estimate for CDNL’s 2026 earnings has increased 14%.
Innodata Inc. (INOD - Free Report) currently sports a Zacks Rank of 1. Innodata has a trailing four-quarter average earnings surprise of 98.9%.
In the past 60 days, the Zacks Consensus Estimate for INOD’s 2026 earnings has remained steady.
Sterling Infrastructure, Inc. (STRL - Free Report) presently sports a Zacks Rank of 1. Sterling Infrastructure delivered a trailing four-quarter average earnings surprise of 29.1%.
In the past 60 days, the consensus estimate for STRL’s 2026 earnings has increased 2.1%.
BridgeBio Pharma BBIO has become a harder stock to judge after its sharp rare-disease run. Attruby is ramping quickly, yet the valuation already assumes a good deal of future success.
Key Takeaways BridgeBio's Attruby became its main revenue driver after strong early sales following FDA approval.BBIO targets three potential U.S. launches over 12 months, led by BBP-418 under priority review.BBIO boosted liquidity with $1B financing, but debt, competition and pipeline risks remain. BridgeBio Pharma (BBIO - Free Report) is moving from a launch-driven story toward a broader commercial execution test. Attruby has quickly become the company’s financial backbone, while late-stage pipeline assets could add new revenue streams.
The stock’s outlook now depends on whether BridgeBio can scale Attruby, convert upcoming regulatory catalysts into launches and manage risks tied to a leveraged rare disease growth model.
Why Attruby Drives BBIO GrowthAttruby is BridgeBio’s key marketed product and main revenue driver. The drug was approved by the FDA in November 2024 for adults with transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive heart disease caused by transthyretin amyloid buildup.
U.S. Attruby sales were $362.4 million in 2025, its first full year on the market, and nearly $181 million in the first quarter of 2026. That performance made the therapy BBIO’s financial backbone.
Growth is tied to rising diagnosis rates, physician adoption and patient uptake. BridgeBio estimates that diagnosed U.S. ATTR-CM patients rose from fewer than 5,000 in 2019 to more than 50,000 in 2025, helped by greater awareness and wider use of non-invasive diagnostic tools.
How BridgeBio Can Broaden RevenueBridgeBio’s next challenge is reducing its dependence on Attruby. The company is preparing for three potential U.S. product launches over the next 12 months, led by BBP-418, encaleret and infigratinib.
BBP-418 is the closest catalyst. The FDA accepted the filing for priority review in limb-girdle muscular dystrophy type 2I/R9, with a decision expected by Nov. 27, 2026. Approval would make it the first therapy for this patient population.
Encaleret adds another possible first-in-class launch. BridgeBio submitted the filing in May 2026 for autosomal dominant hypocalcemia type 1 (ADH1) and anticipates a U.S. launch in early 2027 if approved.
Infigratinib could follow in achondroplasia. BridgeBio intends to file in the third quarter of 2026 and is targeting a potential launch in early to mid-2027. Together, these programs could shift BBIO toward a broader rare disease platform.
BBIO Balance Sheet Supports Launch PlansBridgeBio recently raised $1 billion through preferred equity financing to support current and potential product launches. The capital gives the company more flexibility as it funds Attruby commercialization.
Liquidity looks adequate for near-term needs. BridgeBio ended the first quarter of 2026 with $940.2 million in cash, cash equivalents and marketable securities, up from $587.5 million at the end of 2025.
Debt remains part of the investment case. Long-term debt was approximately $1.93 billion as of March 31, 2026, while short-term debt was around $547 million. The cash balance covers near-term obligations, but BBIO remains a leveraged growth story.
Where BBIO Investors Should Stay CautiousThe biggest risk is concentration. Attruby is BridgeBio’s only approved product in its commercial portfolio, leaving near-term financial performance highly dependent on one therapy.
Competition is another constraint. Pfizer (PFE - Free Report) markets the established Vyndaqel family in ATTR-CM, and BridgeBio must keep proving Attruby’s clinical and access position to gain further share.
Pipeline risk is also material. An FDA delay, rejection, request for more data or narrower-than-expected label for BBP-418, encaleret or infigratinib could push out the diversification timeline.
In achondroplasia, BioMarin Pharmaceutical (BMRN - Free Report) markets Voxzogo, an injectable treatment option. That backdrop means infigratinib’s oral profile may help, but uptake would still depend on data, reimbursement and physician adoption.
How BBIO Fits a Neutral Rating SetupBBIO fits a balanced setup because the positives and risks are both clear. Attruby has delivered meaningful early revenue, the late-stage pipeline offers multiple catalysts and the balance sheet has been strengthened.
At the same time, one-product reliance, regulatory uncertainty and competition keep the risk-reward profile from being one-sided. The stock trades at 12.3X forward 12-month EV/Sales, above the Zacks sub-industry multiple of 2.7X.
A Neutral stance is consistent with a Zacks Rank #3 (Hold) style setup, where investors may prefer to watch execution rather than assume a straight-line growth path. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI - Free Report) or Stryker (SYK - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.
ICU Medical has a Zacks Rank of #2 (Buy), while Stryker has a Zacks Rank of #4 (Sell) right now. Investors should feel comfortable knowing that ICUI likely has seen a stronger improvement to its earnings outlook than SYK has recently. But this is only part of the picture for value investors.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.
ICUI currently has a forward P/E ratio of 19.02, while SYK has a forward P/E of 22.01. We also note that ICUI has a PEG ratio of 1.73. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. SYK currently has a PEG ratio of 2.11.
Another notable valuation metric for ICUI is its P/B ratio of 1.84. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, SYK has a P/B of 5.5.
These are just a few of the metrics contributing to ICUI's Value grade of B and SYK's Value grade of D.
ICUI stands above SYK thanks to its solid earnings outlook, and based on these valuation figures, we also feel that ICUI is the superior value option right now.
, /PRNewswire/ -- Blue Owl Capital Inc. ("Blue Owl") (NYSE: OWL), a leading alternative asset manager, today announced that funds managed by Blue Owl, together with Moor Park Capital Partners ("Moor Park"), have successfully completed the acquisition of a portfolio of 12 acute-care hospitals operated by Spire Healthcare Group plc, the UK's leading private hospital operator.
"The acquisition of the Spire portfolio represents a strategic investment in a portfolio of high-quality UK private hospitals with a market leading tenant, well-structured long-term leases and significantly accelerates the expansion of our European Net Lease strategy," said Marc Zahr, Co-President and Global Head of Real Assets at Blue Owl. "This transaction builds on the firm's experience investing across the healthcare landscape and represents an opportunity to capitalize on the strong supply and demand fundamentals in the European healthcare real estate sector while delivering what we believe to be compelling value for investors and the communities these facilities serve."
The completion of the transaction marks an important milestone for Blue Owl's Real Assets platform and reflects the firm's continued focus on expanding its presence across essential real estate sectors. As part of Blue Owl's Real Assets platform, the Spire portfolio will benefit from the firm's institutional scale, investment expertise and long-standing relationships across the real estate market, creating a strong foundation for continued growth and long-term value creation.
Blue Owl and Moor Park see tremendous opportunity for further growth in the European healthcare sector and will continue to pursue opportunities in the space offering compelling risk-adjusted returns.
The acquisition was financed by a new secured term loan, with Standard Chartered Bank, Natixis and Crédit Agricole CIB acting as joint Mandated Lead Arrangers and lenders to the transaction.
Advisors
Rothschild & Co served as Blue Owl's exclusive financial advisor. Kirkland & Ellis and Hogan Lovells served as Blue Owl's legal counsel. Deloitte served as Blue Owl's tax and financial due diligence advisors.
About Blue Owl
Blue Owl (NYSE: OWL) is a leading asset manager that is redefining alternatives®. With $315 billion in assets under management as of March 31, 2026, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer institutional investors, individual investors, and insurance companies differentiated alternative investment opportunities that aim to deliver strong performance, risk-adjusted returns, and capital preservation.
Together with over 1,390 experienced professionals globally, Blue Owl brings the vision and discipline to create the exceptional. To learn more, visit www.blueowl.com or LinkedIn: https://www.linkedin.com/company/blue-owl-capital.
About Moor Park Capital Partners
Moor Park Capital Partners, founded by Gary Wilder, Shemeel Khan and Jagdeep Kapoor, is a specialist international real estate private equity investment and asset management firm focused on acquiring, financing, developing and managing high-quality operational real estate across healthcare, living, hospitality, logistics, data centres, retail, offices, bank branches, car parks, leisure, service stations and other alternative real estate sectors.
Established more than twenty years ago, the firm has built an internationally recognised reputation for identifying, structuring, financing and executing highly complex, frequently proprietary real estate transactions that are often inaccessible through traditional market channels.
Across their careers, Moor Park's management team has successfully executed transactions with an aggregate value exceeding €26 billion on behalf of sovereign wealth funds, pension funds, insurance companies, managed accounts and other leading global institutional investors, consistently delivering strong long-term investment performance through disciplined investment, active asset management and innovative capital solutions.
Investor Contact
Ann Dai
Head of Investor Relations
[email protected]
Key Takeaways Dillard's blends 272 stores, dillards.com and fresh merchandise to strengthen customer engagement.Total retail sales and comparable-store sales rose 3%, with every merchandise category posting gains.Dillard's opened a 160,000-square-foot Ohio store as the retail gross margin improved to 45.8%. Dillard's, Inc. (DDS - Free Report) has been strengthening its retail position by complementing its physical store network with its digital platform, allowing customers to shop seamlessly across channels. The company’s continued emphasis on merchandising newness, expanding its store footprint and maintaining an established online presence at dillards.com suggests that omnichannel capabilities remain integral to its customer engagement strategy. DDS operates 272 stores across 30 states, alongside its Internet store, providing broad market coverage and multiple shopping touchpoints.
The benefits of this integrated approach are reflected in the first-quarter fiscal 2026 operating results. Total retail sales increased 3%, while comparable-store sales also rose 3%, indicating healthy consumer demand across the business. Notably, every merchandise category posted year-over-year sales gains, with home and furniture, ladies' accessories and lingerie, and shoes delivering the strongest growth. A broader omnichannel presence can help Dillard's showcase these categories more effectively, improve product availability and create a more convenient shopping experience for customers.
Dillard's also continues to invest in its physical network, opening a new 160,000-square-foot store in Beavercreek, OH, in the quarter. Rather than viewing stores and digital channels separately, the company appears positioned to leverage both as complementary assets. Coupled with management's continued focus on refreshing merchandise assortments, this strategy contributed to a higher retail gross margin of 45.8% and profitable sales growth in the fiscal first quarter.
Dillard's combination of an established online platform, nationwide store network and merchandise-led strategy provides a solid foundation to strengthen customer engagement and support long-term competitive positioning.
DDS’s Zacks Rank, Valuation & Share Price PerformanceShares of this Zacks Rank #1 (Strong Buy) company have gained 20.1% in the past year, underperforming the industry and S&P 500’s growth of 47% and 24.1%, respectively. The stock has outpaced the broader Retail-Wholesale sector’s return of 1.8%.
DDS Stock's 3-Month Performance
Image Source: Zacks Investment Research
From a valuation standpoint, DDS trades at a forward price-to-earnings ratio of 15.11X, higher than the industry’s average of 12.67X.
Image Source: Zacks Investment Research
Other Stocks to ConsiderGenesco Inc. (GCO - Free Report) is a specialty retail and branded company that sells footwear and accessories in retail stores throughout the United States, Canada, the U.K. and the Republic of Ireland. The company currently flaunts a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
GCO delivered a trailing four-quarter earnings surprise of 3.8%, on average. The Zacks Consensus Estimate for Genesco’s current financial-year EPS indicates growth of 55.2% from the year-ago reported number.
Tilly's Inc. (TLYS - Free Report) is a specialty retailer in the action sports industry, selling clothing, shoes and accessories. The company currently sports a Zacks Rank #1.
TLYS delivered a trailing four-quarter earnings surprise of 155.3%, on average. The Zacks Consensus Estimate for Tilly's current financial-year sales and EPS indicates growth of 4.9% and 89.7%, respectively, from the year-ago reported numbers.
Urban Outfitters Inc. (URBN - Free Report) is a lifestyle products and services company that sells fashion apparel, accessories, footwear, home goods and related offerings through a portfolio of global consumer brands. The company currently flaunts a Zacks Rank of 1.
The Zacks Consensus Estimate for Urban Outfitters’ current financial-year sales and EPS is expected to rise 8.8% and 11.8%, respectively, from the year-ago reported figures. URBN delivered a trailing four-quarter earnings surprise of 12.2%, on average.
SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction) has achieved sustained GAAP profitability, and CEO Anthony Noto is pushing for aggressive growth. He told investors on the Q1 call, “Over the past 8 years, we’ve grown members by more than 20x from 650,000 to 14.7 million members.”
Yet shares are down 28.92% year to date, trading at $18.61. Can this stock reach $30 in 2027?
Why SoFi Shares Are Stuck Despite Record Fundamentals SoFi posted Q1 results with $1.10 billion in revenue, record loan originations of $12.18 billion (up 68% year over year), and operating income up 150.12% year over year. Why the weakness?
Three factors. First, Technology Platform segment revenue fell 27% year over year after a large client departed. Second, credit is drifting: the personal loan charge-off rate rose to 3.03% from 2.80%. Third, sentiment suffered from the March 2026 Muddy Waters report alleging accounting misstatements. With a beta of 2.15, macro volatility gets amplified.
Shares are up 16.09% over the past month and 2.31% over the past week, but a 1-year return of 0.22% signals the market remains unconvinced.
Wall Street Sees 12% Upside. I Think It Is Too Cautious. The Street consensus target is $20.90, with 3 Strong Buys, 5 Buys, 12 Holds, 2 Sells, and 2 Strong Sells. Our internal model lands at a base case of $20.53, an upside of 10.33%, with a bull scenario at $25.69 and a bear case of $17.93. Model confidence sits at a 90% read, which is unusually strong.
Only 33% of analysts are bullish despite quarterly earnings growth of 101.2% year over year. Analysts are anchoring to trailing loan-book concerns while SoFi’s fee-based flywheel accelerates.
The Path to $30 Per Share Reaching $30 from today’s price of $18.61 would require a gain of 61.2%.
With forward EPS of $0.59, a price of $30 implies a forward P/E of 51. Our base case of $20.53 already implies 42x, meaning the bold target requires roughly 9x of additional multiple expansion.
Is that achievable? Only if EPS growth compresses that number fast. Management guided full-year adjusted EPS of $0.60 and 2025-2028 compounded EPS growth of 38-42%. On that trajectory, $0.59 becomes closer to $1.10 by 2027, which turns 51x into something far more reasonable.
Catalysts include the Composer AI trading platform launched June 23, 2026, SoFi Small Business Loans up to $250,000, and Cathie Wood’s ARK adding roughly 200,000 shares on July 1. Noto framed the ambition simply: “Our one-stop shop is scaling exactly as intended and delivering a winning combination of growth and returns.” The risk: another NIM compression cycle could crush the multiple.
Where SoFi Trades Today vs Its Earnings Power At $18.61 against forward EPS of $0.59, shares trade at roughly 32x forward earnings. That looks rich next to the industry average around 23x, but cheap against a 38-42% EPS growth algorithm.
The stock sits 36% below its 52-week high of $32.73 and well off the low of $14.92. Over the trailing decade, SoFi is up 77.58%. If EPS lands where guidance implies, today’s multiple looks less demanding by the quarter.
Is $30 Realistic? Reaching $30 requires a gain of 61.2%. My verdict: a stretch, but defensible.
Three things need to break right. EPS must compound near the 38-42% guided range. The Technology Platform segment must stabilize and return to 20% to 25% growth. And the Muddy Waters overhang must fade without material accounting revisions. A hard recession that spikes charge-offs would derail it fast. We’ve outlined the blueprint for how SoFi Technologies could reach $30 in 2027.